Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis

References

• Seegmiller AC, Xu Y, McKenna RW, et al. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma. Am J Clin Pathol 2007; 127:176–181.
   PubMed Web of Science ®Google Scholar
• Jaffe ES, Harris NL, Stein H, et al. Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp 158–166.
   Google Scholar
• Zent CS. Chronic B-cell lymphoproliferative disorders: how many diseases? Leuk Lymphoma2006;47:2006–2007.
   Google Scholar
• Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1998;1640–1645.
   Google Scholar
• Calvo KR, McCoy CS, Stetler-Stevenson M. Flow cytometry immunophenotyping of hematolymphoid neoplasia. Methods Mol Biol 2011;699:295–316.
   PubMedGoogle Scholar
• Belov L, Mulligan SP, Barber N, et al. Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray. Br J Haematol 2006;135:184–197.
   PubMed Web of Science ®Google Scholar
• Miguet L, Bechade G, Fornecker L, et al. Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. J Proteome Res 2009;8:3346–3354.
   PubMed Web of Science ®Google Scholar
• Rosenblum MD, Olasz E, Woodliff JE, et al. CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood 2004;103:2691–2698.
   PubMed Web of Science ®Google Scholar
• McCaughan GW, Clark MJ, Hurst J, et al. The gene for mrc OX-2 membrane glycoprotein is localized on human chromosome 3. Immunogenetics 1987;25:133–135.
   PubMed Web of Science ®Google Scholar
• Wright GJ, Jones M, Puklavec MJ, et al. The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 2001;102:173–179.
   PubMed Web of Science ®Google Scholar
• Olteanu H, Harrington AM, Hari P, et al. CD200 expression in plasma cell myeloma. Br J Haematol 2011;153:408–411.
   PubMed Web of Science ®Google Scholar
• Tonks A, Hills R, White P, et al. CD200 as a prognostic factor in acute myeloid leukaemia. Leukemia 2007;21:566–568.
   PubMed Web of Science ®Google Scholar
• Ostman A, Yang Q, Tonks NK. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci USA 1994;91:9680–9684.
   PubMed Web of Science ®Google Scholar
• Sandes AF, de Lourdes Chauffaille M, Oliveira CR, et al. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry. Cytometry B Clin Cytom 2014;86:98–105.
   PubMed Web of Science ®Google Scholar
• El Desoukey NA, Afify RA, Amin DG, et al. CD200 expression in B-cell chronic lymphoproliferative disorders. J Investig Med 2012;60:56–61.
   PubMed Web of Science ®Google Scholar
• Alapat D, Coviello-Malle J, Owens R, et al. Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma. Am J Clin Pathol 2012;137:93–100.
   PubMed Web of Science ®Google Scholar
• Wu YJ, Li JY, Zhu GR, et al. ZAP-70 expression in 24 patients with B-cell chronic lymphocytic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006;14:237–240.
   PubMedGoogle Scholar
• Palumbo GA, Parrinello N, Fargione G, et al. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk Res 2009;33:1212–1216.
   PubMed Web of Science ®Google Scholar
• Xu W, Li JY, Wu YJ, et al. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia. Leuk Res 2009;33:237–243.
   PubMed Web of Science ®Google Scholar
• Shao H, Calvo KR, Gronborg M, et al. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. Leuk Res 2013;37:401–409.
   PubMed Web of Science ®Google Scholar
• Sanchez ML, Almeida J, Lopez A, et al. Biclonality versus intraclonal evolution of a single tumor cell clone. Haematologica 2006;91:331–339.
   PubMed Web of Science ®Google Scholar
• Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008;111:3941–3967.
   PubMed Web of Science ®Google Scholar
• Schlette E, Fu K, Medeiros LJ. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol 2003;120:760–766.
   PubMed Web of Science ®Google Scholar
• Dorfman DM, Shahsafaei A. CD200 (OX-2 membrane glycoprotein) expression in B cell-derived neoplasms. Am J Clin Pathol 2010;134:726–733.
   PubMed Web of Science ®Google Scholar
• Dearden C. B- and T-cell prolymphocytic leukemia: antibody approaches. Hematology Am Soc Hematol Educ Program 2012;2012:645–651.
   PubMed Web of Science ®Google Scholar
• Dungarwalla M, Matutes E, Dearden CE. Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. Eur J Haematol 2008;80:469–476.
   PubMed Web of Science ®Google Scholar
• Dong HY, Shahsafaei A, Dorfman DM. CD148 and CD27 are expressed in B cell lymphomas derived from both memory and naive B cells. Leuk Lymphoma 2002;43:1855–1858.
   PubMed Web of Science ®Google Scholar
• Kretz-Rommel A, Qin F, Dakappagari N, et al. Blockade of CD200 in the presence or absence of antibody effector function: implications for anti-CD200 therapy. J Immunol 2008;180:699–705.
   PubMed Web of Science ®Google Scholar
• Kretz-Rommel A, Qin F, Dakappagari N, et al. CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy. J Immunol 2007;178:5595–5605.
   PubMed Web of Science ®Google Scholar
• Kretz-Rommel A, Bowdish KS. Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression. Expert Opin Biol Ther 2008;8:5–15.
   PubMed Web of Science ®Google Scholar